Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Agilent Introduces New ProPulse NMR Platform

Published: Tuesday, November 12, 2013
Last Updated: Tuesday, November 12, 2013
Bookmark and Share
Compact system provides simple, walk-up performance for applied chemistry research, drug discovery, food science and metabolomics.

Agilent Technologies Inc. introduce a nuclear magnetic resonance spectroscopy platform ideal for use in academic, pharmaceutical and applied chemical laboratories. The ProPulse NMR System brings true ease-of-use to high-performance NMR.

The compact ProPulse 500 and 600 MHz NMR System comes standard with Agilent's VnmrJ software, providing users with a comprehensive, intuitive interface to generate high-quality data with increased speed and simplicity. The combined hardware-software system empowers researchers to easily perform complex NMR experiments with consistent results.

The ProPulse NMR System integrates uncompromised Agilent DirectDrive console performance into an advanced, compact, space-efficient platform. Other key tools and benefits include:

• The VeriPulse tool-kit, which automatically optimizes performance and minimizes maintenance costs.
• Wireless remote status tablet compatibility that makes system monitoring possible and simple from anywhere in the lab.
• Easy siting, streamlined system interconnects, and standard power interface.
• High-quality data for software applications, such as CRAFT (Complete Reduction to Amplitude and Frequency Table), that extends NMR into data-intense applications, such as reaction monitoring or metabolomics, to deliver fast results.
• Compatibility with existing NMR magnets.

"We are excited to offer a new platform that enables automated, small-molecule NMR analysis," said Regina Schuck, Ph.D., vice president and general manager of Agilent's Research Products Division. "This simple yet powerful system increases the effectiveness of NMR users of all levels. We are setting a new standard by offering researchers an NMR system that accelerates their speed-to-productivity through intuitive and highly automated experimental setup and maintenance."

Agilent offers a complete portfolio of nuclear magnetic resonance solutions for research and industrial applications that can be used to analyze both small- and large-molecule compounds. Agilent's NMR spectroscopy systems are modular, ranging in size and capacity according to their intended use. The company supplies these products to a wide range of industries including chemical, pharmaceutical, food science, metabolomics and more.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Agilent Collaborating with Florida International University
Collaboration to further advance the identification and characterization of designer drugs.
Tuesday, February 26, 2013
Agilent Technologies and Ameritox Form Collaboration
Agilent Technologies Inc. and AmeritoxSM announced that they have formed a research collaboration that could accelerate analysis in the field of medication monitoring.
Tuesday, February 12, 2013
Agilent and Johns Hopkins to Research Toxicity Pathways for Embryonic Brain Development Using Metabolomics
The work could help identify possible contributions of chemicals to disorders such as autism and attention hyperactivity disorders.
Friday, August 20, 2010
Agilent and National Institute for Bioprocessing Research and Training, Advance Emerging Glycomics Research
NIBRT's Professor Pauline Rudd has been granted an Agilent Thought Leader Award in support of her emerging glycomics research.
Wednesday, June 30, 2010
Agilent Instruments Selected by South African Doping Control Laboratory for 2010 World Cup
The Company has been selected by as the primary provider of gas-phase testing instruments for the 2010 World Cup.
Wednesday, June 16, 2010
BIOCIUS and Agilent Launch High-throughput, RapidFire® Mass Solution for Drug Discovery
Advanced, integrated system for high quality in vitro ADME analysis unveiled at ASMS Conference, May 23-May 27.
Friday, May 21, 2010
Agilent and the National Center for Food Safety and Technology Collaborate to Develop Food Testing Methods
The collaboration will develop new scientific methods for food testing to solve problems facing global food supply chains.
Wednesday, March 03, 2010
Novel Automated Stem Cell High Content Screening Platform
A new technical poster describes how researchers at I-STEM have used a BioCel 1800 platform for muscular dystrophy therapeutic research.
Friday, June 19, 2009
Agilent Introduces Service to Help GC and LC Labs Demonstrate Test Quality and Calibration
Service leverages expertise in Pharma into chemical, food, flavors, forensics, other labs seeking ISO/IEC 17024-type certification.
Wednesday, June 17, 2009
Agilent Technologies and Anderson Forschung Group Collaborate on Quantitative Protein Assays
The collaboration will combine AFG’s SISCAPA technology with Agilent’s HPLC-Chip and triple quadrupole MS to speed protein biomarker discovery and validation.
Wednesday, June 03, 2009
Agilent Technologies Completes Large-Scale Expansion of Nucleic Acid Manufacturing Capacity
Major expansion enables the company to manufacture several hundred kilograms of therapeutic oligonucleotides per year.
Friday, May 08, 2009
Agilent Technologies Hosts Anti-Doping Agency Officials
The China Anti-Doping Agency to use Agilent instrumentation to confirm the chemical identity of suspected banned substances found in testing samples.
Friday, May 23, 2008
Agilent Technologies Acquires Kalabie Electronic Laboratory Notebook from Klee Group
Agilent expands informatics portfolio with electronic notebook for life sciences, chemical analysis after acquiring Kalabie.
Tuesday, June 19, 2007
Regulators OK Agilent buy of Stratagene
Federal Antitrust Regulators Approve Agilent's Purchase of Stratagene
Monday, May 14, 2007
Agilent Technologies Announces Creation of new Business Unit in Life Sciences and Chemical Analysis
The new business unit will focus on developing a microscopy and optical spectroscopy business that can be leveraged into the electronics, materials testing, life sciences and chemical analysis markets.
Monday, April 02, 2007
Scientific News
Keeping Tumor Growth at Bay
Engineers at Washington University in St. Louis found a way to keep a cancerous tumor from growing by using nanoparticles of the main ingredient in common antacid tablets.
Future of Medicine Could be Found in a Tiny Crystal Ball
A Drexel University materials scientist has discovered a way to grow a crystal ball in a lab. Not the kind that soothsayers use to predict the future, but a microscopic version that could be used to encapsulate medication in a way that would allow it to deliver its curative payload more effectively inside the body.
Improving Delivery of Poorly Soluble Drugs Using Nanoparticles
A technology that could forever change the delivery of drugs is undergoing evaluation by the Technology Evaluation Consortium™ (TEC). Developed by researchers at Northeastern University, the technology is capable of creating nanoparticle structures that could deliver drugs into the bloodstream orally – despite the fact that they are normally poorly soluble.
Faster Drug Discovery?
Startup develops more cost-effective test for assessing how cells respond to chemicals.
New Mechanism of Antitumor Action Identified
A team of UAB researchers and collaborators from the Catalan biotech company Ability Pharmaceuticals (UAB Research Park), have described a new mechanism of anti-tumour action, identified during the study and development of the new drug ABTL0812.
Nanoparticles Deliver Tumor Suppressors to Damaged Livers
UT Southwestern Medical Center chemists have successfully used synthetic nanoparticles to deliver tumor-suppressing therapies to diseased livers with cancer, an important hurdle scientists have been struggling to conquer.
Experimental Combination Surprises with Anti-HIV Effectiveness
A compound developed to protect the nervous system from HIV surprised researchers by augmenting the effectiveness of an investigational antiretroviral drug beyond anything expected.
A New Type of Anticancer Agent
Success in the development of a ?-tubulin specific inhibitor.
Nanoparticles Proven Effective Against Antibiotic-Resistant “Superbugs”
In the ever-escalating evolutionary battle with drug-resistant bacteria, humans may soon have a leg up thanks to adaptive, light-activated nanotherapy developed by researchers at the University of Colorado Boulder.
Versatile New Molecule-Building Technique
Chemists at The Scripps Research Institute (TSRI) have devised a new and widely applicable technique for building potential drug molecules and other organic compounds.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!